Dáil Éireann Debate, Tuesday - 16 January 2018
826. Deputy John Brassil asked the Minister for Health if the availability of Vimizim will be considered as a priority at the upcoming HSE drug group meeting on 18 January 2018; and if he will make a statement on the matter. [54971/17]
View answerThe HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
